Michael Wilmink, Director at Eupraxia Pharmaceuticals, holds 222.97K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, Michael Wilmink Bought C$1,100 shares of Eupraxia Pharmaceuticals on Jun 18, 2024 for an estimated value of 2.93K.